Form 10-K BioXcel Therapeutics, For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260327/AJBEG22C8W22U2ZU222D2MZZEUKDZ2R2Z282
Filed on: March 27, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Statement from Brera Holdings (NASDAQ: SLMT)(“Solmate Infrastructure” or “the Company”)
- Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
- The Real Brokerage Surpasses 35,000 Agents as Company Celebrates 12 Years of Agent-First Innovation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
